Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome

Weill Cornell Medical Center, New York

Center for Cancer and Blood Disorders, Bethesda

Sidney Kimmel Comprehensive Cancer at Johns Hopkins, Baltimore

Florida Cancer Specialist and Research Institute, Tallahassee

Woodlands Medical Specialists, Pensacola

H. Lee Moffitt Cancer Center, Tampa

Florida Cancer Specialists North, St. Petersburg

Florida Cancer Specialists South, Fort Myers

Southern Cancer Center, Mobile

Sarah Cannon Cancer Center, Tennessee Oncology, Nashville

Tennessee Oncology - Chattanooga, Chattanooga

Cleveland Clinic Foundation, Cleveland

Oncology Hematology Care, Cincinnati

Indiana University Simon Cancer Ctr, Indianapolis

Fort Wayne Medical Oncology and Hematology, Fort Wayne

Henry Ford Hospital, Detroit

Michigan State University, Lansing

Nebraska Methodist, Omaha

MD Anderson Cancer Center, Houston

Cancer Care Centers of South Texas, San Antonio

Colorado Blood Cancer Institute, Denver

Comprehensive Cancer Centers of Nevada, Las Vegas

Scripps Cancer Center, La Jolla

Swedish Cancer Institute, Seattle